Informação sobre produto
2-(Pyridin-3-yl)propanoic acid is a quinoline derivative that has been shown to be safe and effective in clinical trials. It is being tested for the treatment of type 2 diabetes, obesity, and metabolic syndrome. The oral administration of this drug inhibits the activity of dipeptidyl peptidase-4 (DPP-4), which is an enzyme involved in the degradation of insulin. This inhibition leads to increased levels of insulin in the blood and improved glucose tolerance. 2-(Pyridin-3-yl)propanoic acid interacts with other drugs through competitive inhibition at their binding sites on enzymes. Optimization experiments have shown that it can interact with pyridine compounds, which are found in many drugs including acetaminophen and caffeine.
Propriedades químicas
Consulta técnica sobre: 3D-QDA00562 2-(Pyridin-3-yl)propanoic acid
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
